8-KOther Events

CARDINAL HEALTH INC 8-K Report (May 9, 2002)

Filed May 9, 2002For Securities:CAH

Summary

Cardinal Health, Inc. (CAH) filed an 8-K report on May 9, 2002, to announce a significant change in its independent auditor. Effective May 8, 2002, the Company's Board of Directors, on the recommendation of its Audit Committee, dismissed Arthur Andersen LLP as its independent registered public accounting firm. Concurrently, Cardinal Health engaged Ernst & Young LLP to serve as its auditor for the fiscal year ending June 30, 2002. This change in auditors, especially the dismissal of Arthur Andersen at a time when Arthur Andersen was facing significant scrutiny, is a key event for investors to note. The filing explicitly states that there were no disagreements on accounting principles, financial statement disclosures, or auditing procedures between Cardinal Health and Arthur Andersen that would have led to Arthur Andersen referencing such issues in their audit reports for fiscal years 2001 and 2000. The company also confirmed no prior consultations with Ernst & Young regarding specific accounting matters or potential audit opinions.

Key Highlights

  • 1Cardinal Health, Inc. (CAH) has changed its independent auditor.
  • 2Arthur Andersen LLP has been dismissed as the Company's independent public accountants.
  • 3Ernst & Young LLP has been engaged as the new independent public accountants for the fiscal year ending June 30, 2002.
  • 4The dismissal of Arthur Andersen was effective May 8, 2002.
  • 5The Board of Directors approved the change upon the recommendation of the Audit Committee.
  • 6The filing explicitly states no disagreements with Arthur Andersen on accounting principles, disclosures, or auditing procedures for fiscal years 2001 and 2000.
  • 7There were no reportable events as defined by Regulation S-K that would require specific disclosure regarding the dismissal.

Frequently Asked Questions

The 8-K filing states that the Board of Directors, on the recommendation of the Audit Committee, dismissed Arthur Andersen and engaged Ernst & Young. While the filing does not provide a specific reason beyond the formal dismissal, it is important to note that this change occurred in May 2002, a period of intense scrutiny and eventual collapse for Arthur Andersen due to its role in the Enron scandal. Investors may infer external factors influenced this decision.

No, the filing explicitly states that there were no disagreements between Cardinal Health and Arthur Andersen on any matter of accounting principle or practice, financial statement disclosure, or auditing scope or procedure. This suggests a clean break without unresolved accounting issues.

The report indicates that Cardinal Health did not consult with Ernst & Young regarding the application of accounting principles to any specified transaction, the type of audit opinion that might be rendered, or other matters listed in Regulation S-K prior to engaging them. This implies the engagement was a straightforward selection of a new auditor.

Exhibit 16 is a letter from Arthur Andersen LLP to the SEC, dated May 9, 2002. This letter serves to confirm Arthur Andersen's agreement with the disclosures made by Cardinal Health in this 8-K filing regarding the dismissal and the absence of any disagreements. This provides external validation of the company's statements about the auditor change.